Click on the Chapters icon in the video toolbar to navigate through the sections of the video.
The video features leading experts discussing the latest advancements and challenges in treating multiple myeloma, focusing on therapies like CAR-T cells and bispecific antibodies. They highlight strategies for managing side effects, particularly infection risks and cardiotoxicity, emphasizing patient education and proactive management. The conversation also explores the potential of new drug combinations and personalized treatment approaches to balance efficacy with quality of life.
Date of original release: 30 October 2024
Date credits expire: 30 October 2025
This webinar has been supported by an independent educational grant from Janssen Pharmaceuticals. Janssen Pharmaceuticals has had no influence over the content or selection of the Editorial Panel.
ACCREDITATIONS:
John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Wiley designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM per e-learning. Physicians should claim only the credit commensurate with the extent of their participation in the activity.